(1S-trans)-Methyl 3-hydroxycyclohexanecarboxylate, 97+%, 1g

2-Bromo-3-methylthiophene>98.0%(GC)25g

(S)-Ethyl 2-hydroxy-4-phenylbutanoate, 95.0%, 10g

Potassium 2-methylbutan-2-olate, 98%, 100g

DIPHENYL(QUINUCLIDIN-4-YL)METHANOL, 95.0%, 1g

1-BENZYL 4-METHYL 4-AMINOPIPERIDINE-1,4-DICARBOXYLATE HCL, 90.0%, 500mg

(2R,3R,4S,5R)-2-(6-Amino-8-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97%, 100mg

AZTAK1 INHIBITOR, 98.0%, 25mg

1-(3-CHLORO-5-FLUORO-PHENYL)-2,2,2-TRIFLUORO-ETHYLAMINE, 95.0%, 250mg

6,7-Difluoro-1H-benzo[d]imidazole-2-carboxylic acid, 97.0%, 1g

2-CYCLOHEXYLPYRROLIDINE, 95.0%, 250mg

ETHYL 7-BROMO-3-(3-ETHOXY-3-OXOPROPYL)-1H-INDOLE-2-CARBOXYLATE, 95.0%, 500mg

Methyl 4-amino-1H-pyrazole-3-carboxylate, 95.0%, 10g